US Stock MarketDetailed Quotes

TDOC Teladoc Health

Watchlist
  • 10.990
  • -0.190-1.70%
Close Feb 26 16:00 ET
  • 9.300
  • -1.690-15.38%
Pre 05:57 ET
1.91BMarket Cap-1.87P/E (TTM)

Teladoc Health Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-16.10%293.68M
-33.96%85.9M
4.33%110.18M
-12.35%88.68M
-32.20%8.92M
84.91%350.02M
98.45%130.08M
67.56%105.6M
9.42%101.18M
141.44%13.16M
Net income from continuing operations
-354.35%-1B
-67.56%-48.41M
41.70%-33.28M
-1,185.22%-837.67M
-18.29%-81.89M
98.39%-220.37M
99.24%-28.89M
22.32%-57.07M
97.90%-65.18M
98.96%-69.23M
Depreciation and amortization
8.97%382.84M
-11.38%91.67M
-5.20%91.81M
26.43%98.85M
37.98%100.51M
29.81%351.32M
31.15%103.45M
48.01%96.85M
23.22%78.19M
15.85%72.84M
Deferred tax
39.83%-1.15M
-136.93%-1.76M
75.59%-757K
192.69%2.97M
-350.70%-1.6M
75.73%-1.9M
350.53%4.76M
9.17%-3.1M
-1,432.06%-3.2M
84.69%-355K
Other non cash items
217.02%9.8M
168.72%4.58M
15.78%2.52M
-70.25%1.29M
-56.75%1.4M
-71.73%3.09M
-240.26%-6.67M
-51.84%2.17M
421.37%4.34M
292.74%3.24M
Change In working capital
-411.90%-36.32M
-1.12%10.74M
21.34%14.44M
-129.92%-9.59M
-20.23%-51.91M
124.06%11.64M
145.98%10.87M
5.39%11.9M
-32.64%32.05M
48.38%-43.18M
-Change in receivables
96.34%-375K
57.62%-4.05M
4.89%6.65M
-172.77%-5.1M
115.19%2.13M
79.10%-10.25M
-152.07%-9.56M
580.36%6.34M
143.55%7.01M
49.55%-14.05M
-Change in inventory
-140.46%-9.75M
-124.29%-1.42M
3.00%-2.3M
-127.71%-2.94M
-130.91%-3.09M
62.80%24.1M
436.11%5.85M
-236.43%-2.37M
6.65%10.61M
394.32%10M
-Change in prepaid assets
-58.37%5.19M
245.37%2.34M
720.98%15.87M
-53.16%10.67M
-284.28%-23.69M
130.33%12.46M
15.49%-1.61M
86.54%-2.56M
1,996.01%22.79M
67.54%-6.17M
-Change in payables and accrued expense
-102.85%-686K
-3.89%27.13M
-76.71%5.22M
40.60%-376K
-25.87%-32.66M
-52.63%24.06M
350.19%28.23M
-30.57%22.42M
-100.95%-633K
29.15%-25.95M
-Change in other current assets
94.55%-1.26M
42.52%-2.7M
184.87%763K
95.57%-333K
110.15%1.01M
16.98%-23.05M
4.54%-4.69M
83.35%-899K
34.03%-7.52M
-64.36%-9.94M
-Change in other current liabilities
-3.87%-11.19M
25.55%-2.77M
-32.25%-2.94M
-22.27%-2.58M
-6.60%-2.91M
4.87%-10.77M
35.53%-3.72M
-249.50%-2.22M
38.37%-2.11M
24.88%-2.73M
-Change in other working capital
-272.37%-18.25M
-114.07%-7.79M
-0.12%-8.82M
-570.76%-8.94M
29.20%7.3M
-132.15%-4.9M
-224.24%-3.64M
-691.87%-8.81M
-43.24%1.9M
-24.48%5.65M
Cash from discontinued investing activities
Operating cash flow
-16.10%293.68M
-33.96%85.9M
4.33%110.18M
-12.35%88.68M
-32.20%8.92M
84.91%350.02M
98.45%130.08M
67.56%105.6M
9.42%101.18M
141.44%13.16M
Investing cash flow
Cash flow from continuing investing activities
20.66%-124.05M
18.80%-29.64M
17.26%-31.15M
24.12%-27.75M
22.16%-35.51M
6.79%-156.35M
32.26%-36.51M
9.17%-37.65M
18.44%-36.57M
-65.50%-45.62M
Capital expenditure reported
20.66%-124.05M
18.80%-29.64M
17.26%-31.15M
24.12%-27.75M
22.16%-35.51M
9.50%-156.35M
32.26%-36.51M
12.86%-37.65M
18.44%-36.57M
-47.98%-45.62M
Net business purchase and sale
----
----
----
----
----
--0
----
----
----
----
Net investment purchase and sale
----
----
----
----
----
--0
----
----
----
----
Net other investing changes
----
----
----
----
----
-99.96%1K
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
20.66%-124.05M
18.80%-29.64M
17.26%-31.15M
24.12%-27.75M
22.16%-35.51M
6.79%-156.35M
32.26%-36.51M
9.17%-37.65M
18.44%-36.57M
-65.50%-45.62M
Financing cash flow
Cash flow from continuing financing activities
-23.42%8.31M
215.94%2.06M
-86.23%698K
-9.58%3.81M
-47.78%1.75M
67.06%10.85M
-140.52%-1.78M
699.37%5.07M
415.44%4.21M
19.07%3.35M
Proceeds from stock option exercised by employees
-25.31%8.31M
69.24%1.88M
-75.51%957K
24.08%3.83M
-45.59%1.65M
-10.12%11.13M
-66.84%1.11M
87.88%3.91M
1,085.62%3.09M
-58.33%3.03M
Net other financing activities
99.28%-2K
106.10%176K
-122.33%-259K
-102.05%-23K
-68.10%104K
95.28%-278K
-380.84%-2.89M
180.22%1.16M
209.99%1.12M
107.33%326K
Cash from discontinued financing activities
Financing cash flow
-23.42%8.31M
215.94%2.06M
-86.23%698K
-9.58%3.81M
-47.78%1.75M
67.06%10.85M
-140.52%-1.78M
699.37%5.07M
415.44%4.21M
19.07%3.35M
Net cash flow
Beginning cash position
22.38%1.12B
20.70%1.24B
21.25%1.16B
23.56%1.1B
22.38%1.12B
2.76%918.18M
14.55%1.03B
8.80%958.7M
6.23%888.58M
2.76%918.18M
Current changes in cash
-13.00%177.94M
-36.48%58.32M
9.18%79.73M
-5.93%64.74M
14.68%-24.84M
629.26%204.53M
472.36%91.8M
228.82%73.02M
48.65%68.82M
48.47%-29.12M
Effect of exchange rate changes
-440.73%-3.29M
-386.19%-3.86M
247.73%1.76M
-122.53%-292K
-84.22%-899K
128.86%965K
-46.38%1.35M
68.16%-1.19M
181.97%1.3M
9.29%-488K
End cash Position
15.54%1.3B
15.54%1.3B
20.70%1.24B
21.25%1.16B
23.56%1.1B
22.38%1.12B
22.38%1.12B
14.55%1.03B
8.80%958.7M
6.23%888.58M
Free cash flow
-12.42%169.63M
-39.88%56.26M
16.29%79.03M
-5.69%60.94M
18.10%-26.59M
1,071.79%193.67M
702.67%93.58M
242.92%67.95M
35.65%64.61M
48.12%-32.47M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -16.10%293.68M-33.96%85.9M4.33%110.18M-12.35%88.68M-32.20%8.92M84.91%350.02M98.45%130.08M67.56%105.6M9.42%101.18M141.44%13.16M
Net income from continuing operations -354.35%-1B-67.56%-48.41M41.70%-33.28M-1,185.22%-837.67M-18.29%-81.89M98.39%-220.37M99.24%-28.89M22.32%-57.07M97.90%-65.18M98.96%-69.23M
Depreciation and amortization 8.97%382.84M-11.38%91.67M-5.20%91.81M26.43%98.85M37.98%100.51M29.81%351.32M31.15%103.45M48.01%96.85M23.22%78.19M15.85%72.84M
Deferred tax 39.83%-1.15M-136.93%-1.76M75.59%-757K192.69%2.97M-350.70%-1.6M75.73%-1.9M350.53%4.76M9.17%-3.1M-1,432.06%-3.2M84.69%-355K
Other non cash items 217.02%9.8M168.72%4.58M15.78%2.52M-70.25%1.29M-56.75%1.4M-71.73%3.09M-240.26%-6.67M-51.84%2.17M421.37%4.34M292.74%3.24M
Change In working capital -411.90%-36.32M-1.12%10.74M21.34%14.44M-129.92%-9.59M-20.23%-51.91M124.06%11.64M145.98%10.87M5.39%11.9M-32.64%32.05M48.38%-43.18M
-Change in receivables 96.34%-375K57.62%-4.05M4.89%6.65M-172.77%-5.1M115.19%2.13M79.10%-10.25M-152.07%-9.56M580.36%6.34M143.55%7.01M49.55%-14.05M
-Change in inventory -140.46%-9.75M-124.29%-1.42M3.00%-2.3M-127.71%-2.94M-130.91%-3.09M62.80%24.1M436.11%5.85M-236.43%-2.37M6.65%10.61M394.32%10M
-Change in prepaid assets -58.37%5.19M245.37%2.34M720.98%15.87M-53.16%10.67M-284.28%-23.69M130.33%12.46M15.49%-1.61M86.54%-2.56M1,996.01%22.79M67.54%-6.17M
-Change in payables and accrued expense -102.85%-686K-3.89%27.13M-76.71%5.22M40.60%-376K-25.87%-32.66M-52.63%24.06M350.19%28.23M-30.57%22.42M-100.95%-633K29.15%-25.95M
-Change in other current assets 94.55%-1.26M42.52%-2.7M184.87%763K95.57%-333K110.15%1.01M16.98%-23.05M4.54%-4.69M83.35%-899K34.03%-7.52M-64.36%-9.94M
-Change in other current liabilities -3.87%-11.19M25.55%-2.77M-32.25%-2.94M-22.27%-2.58M-6.60%-2.91M4.87%-10.77M35.53%-3.72M-249.50%-2.22M38.37%-2.11M24.88%-2.73M
-Change in other working capital -272.37%-18.25M-114.07%-7.79M-0.12%-8.82M-570.76%-8.94M29.20%7.3M-132.15%-4.9M-224.24%-3.64M-691.87%-8.81M-43.24%1.9M-24.48%5.65M
Cash from discontinued investing activities
Operating cash flow -16.10%293.68M-33.96%85.9M4.33%110.18M-12.35%88.68M-32.20%8.92M84.91%350.02M98.45%130.08M67.56%105.6M9.42%101.18M141.44%13.16M
Investing cash flow
Cash flow from continuing investing activities 20.66%-124.05M18.80%-29.64M17.26%-31.15M24.12%-27.75M22.16%-35.51M6.79%-156.35M32.26%-36.51M9.17%-37.65M18.44%-36.57M-65.50%-45.62M
Capital expenditure reported 20.66%-124.05M18.80%-29.64M17.26%-31.15M24.12%-27.75M22.16%-35.51M9.50%-156.35M32.26%-36.51M12.86%-37.65M18.44%-36.57M-47.98%-45.62M
Net business purchase and sale ----------------------0----------------
Net investment purchase and sale ----------------------0----------------
Net other investing changes ---------------------99.96%1K----------------
Cash from discontinued investing activities
Investing cash flow 20.66%-124.05M18.80%-29.64M17.26%-31.15M24.12%-27.75M22.16%-35.51M6.79%-156.35M32.26%-36.51M9.17%-37.65M18.44%-36.57M-65.50%-45.62M
Financing cash flow
Cash flow from continuing financing activities -23.42%8.31M215.94%2.06M-86.23%698K-9.58%3.81M-47.78%1.75M67.06%10.85M-140.52%-1.78M699.37%5.07M415.44%4.21M19.07%3.35M
Proceeds from stock option exercised by employees -25.31%8.31M69.24%1.88M-75.51%957K24.08%3.83M-45.59%1.65M-10.12%11.13M-66.84%1.11M87.88%3.91M1,085.62%3.09M-58.33%3.03M
Net other financing activities 99.28%-2K106.10%176K-122.33%-259K-102.05%-23K-68.10%104K95.28%-278K-380.84%-2.89M180.22%1.16M209.99%1.12M107.33%326K
Cash from discontinued financing activities
Financing cash flow -23.42%8.31M215.94%2.06M-86.23%698K-9.58%3.81M-47.78%1.75M67.06%10.85M-140.52%-1.78M699.37%5.07M415.44%4.21M19.07%3.35M
Net cash flow
Beginning cash position 22.38%1.12B20.70%1.24B21.25%1.16B23.56%1.1B22.38%1.12B2.76%918.18M14.55%1.03B8.80%958.7M6.23%888.58M2.76%918.18M
Current changes in cash -13.00%177.94M-36.48%58.32M9.18%79.73M-5.93%64.74M14.68%-24.84M629.26%204.53M472.36%91.8M228.82%73.02M48.65%68.82M48.47%-29.12M
Effect of exchange rate changes -440.73%-3.29M-386.19%-3.86M247.73%1.76M-122.53%-292K-84.22%-899K128.86%965K-46.38%1.35M68.16%-1.19M181.97%1.3M9.29%-488K
End cash Position 15.54%1.3B15.54%1.3B20.70%1.24B21.25%1.16B23.56%1.1B22.38%1.12B22.38%1.12B14.55%1.03B8.80%958.7M6.23%888.58M
Free cash flow -12.42%169.63M-39.88%56.26M16.29%79.03M-5.69%60.94M18.10%-26.59M1,071.79%193.67M702.67%93.58M242.92%67.95M35.65%64.61M48.12%-32.47M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
WANDA BEARING
920002
+30.00%
HENDERA
831152
+29.97%
LINGOOD
833284
+29.95%
4
WUHAN LAND
830779
+25.43%
5
TECHVISION
832876
+21.28%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
Widespread uptick! What's ahead for Chinese stocks in 2025?
Recently, institutions such as Goldman Sachs, Morgan Stanley, and Appaloosa LP have spoken positively about Chinese assets. Chinese stocks l Show More
Chinese Stocks' Wild Rally Hits Pause? Wall Street Still Bets Big on Favorites